Zacks Investment Research on MSN1h
Arch Capital Stock Trades Above 50-Day SMA: Time to Buy?
Arch Capital Group Ltd. ACGL has been trading above its 50-day simple moving average (SMA), signaling a short-term bullish ...
Zacks Investment Research on MSN1d
Beat the Market the Zacks Way: Amgen, DRDGOLD, Anavex in Focus
Last Friday, the three most widely followed benchmark indexes closed a losing week. The S&P 500, the Nasdaq Composite and the ...
Zacks Industry Outlook Highlights Coca-Cola, PepsiCo, Monster Beverage, Keurig Dr Pepper and Primo Brands
Coca-Cola, PepsiCo, Monster Beverage, Keurig Dr Pepper and Primo Brands are part of the Zacks Industry Outlook article.
Zacks Research Issues Positive Estimate for AWK Earnings
Analysts at Zacks Research lifted their Q1 2025 earnings estimates for shares of American Water Works in a research report ...
Zacks Research Has Negative Estimate for CRL Q1 Earnings
Research analysts at Zacks Research decreased their Q1 2025 earnings per share (EPS) estimates for Charles River Laboratories ...
Zacks.com on MSN8d
Zacks Investment Ideas feature highlights: Alphabet, Amazon and Meta Platforms
Today, Zacks Investment Ideas feature highlights Alphabet GOOGL, Amazon AMZN and Meta Platforms META. Big Tech Discounts I ...
Nasdaq12d
Zacks Investment Ideas feature highlights NVIDIA, Vertiv and Palantir
Chicago, IL – March 6, 2025 – Today, Zacks Investment Ideas feature highlights NVIDIA NVDA, Vertiv VRT and Palantir PLTR. Are These AI Stocks on Sale? The AI trade has temporarily run into a ...
Zevra Therapeutics: Q4 Earnings Snapshot
CELEBRATION, Fla. — CELEBRATION, Fla. — Zevra Therapeutics, Inc. (ZVRA) on Tuesday reported a loss of $35.7 million in its fourth quarter. The Celebration, Florida-based company said it had a loss of ...